Phase II multicenter study of oblimersen sodium, a Bcl-2...

Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma

Barbara Pro, Brian Leber, Mitchell Smith, Luis Fayad, Jorge Romaguera, Fredrick Hagemeister, Alma Rodriguez, Peter McLaughlin, Felipe Samaniego, James Zwiebel, Adriana Lopez, Larry Kwak, Anas Younes
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
143
Year:
2008
Language:
english
Pages:
6
DOI:
10.1111/j.1365-2141.2008.07353.x
File:
PDF, 168 KB
english, 2008
Conversion to is in progress
Conversion to is failed